3-iodobenzylguanidine has been researched along with Alloxan Diabetes in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cappellini, C; Kusmic, C; L'abbate, A; Marini, C; Marzullo, P; Matteucci, M; Morbelli, S; Pomposelli, E; Sambuceti, G | 1 |
Fujii, N; Igarashi, N; Igawa, A; Inoue, H; Matsuki, A; Nozawa, T; Ohori, T; Sobajima, M; Suzuki, T | 1 |
Aust, W; Fitzl, G; Kluge, R; Löster, H; Schneider, R; Welt, K | 1 |
Fujiwara, H; Kajiyama, S; Kanegawa, N; Kiyono, Y; Saji, H | 2 |
Dai, S; Hartman, NG; Herman, LM; McNeill, JH | 1 |
Batink, HD; Boer, GJ; de Bruin, K; Dubois, EA; Kam, KL; Pfaffendorf, M; Somsen, GA; van Royen, EA; van Zwieten, PA | 1 |
Kurata, C; Mikami, T; Okayama, K; Shouda, S; Sugiyama, T; Tawarahara, K; Wakabayashi, Y | 1 |
Iida, Y; Kawashima, H; Kiyono, Y; Nishimura, H; Saji, H; Tamaki, N | 1 |
9 other study(ies) available for 3-iodobenzylguanidine and Alloxan Diabetes
Article | Year |
---|---|
Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Kinetics; Liver; Male; Mice; Mice, Inbred C57BL; Myocardium; Norepinephrine; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Fluvastatin attenuates diabetes-induced cardiac sympathetic neuropathy in association with a decrease in oxidative stress.
Topics: 3-Iodobenzylguanidine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dinoprost; Fatty Acids, Monounsaturated; Fluvastatin; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Iodine Radioisotopes; Male; Myocardium; NADPH Oxidases; Oxidative Stress; Radionuclide Imaging; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Triglycerides | 2010 |
Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761.
Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diabetic Neuropathies; Fluorescent Antibody Technique; Free Radical Scavengers; Ginkgo biloba; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Myocardium; Plant Extracts; Radionuclide Imaging; Radiopharmaceuticals; Rats | 2010 |
Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Topics: 3-Iodobenzylguanidine; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Heart; Male; Metabolic Clearance Rate; Myocardium; Norepinephrine Plasma Membrane Transport Proteins; Polymers; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Rhodanine; Signal Transduction; Sorbitol; Streptozocin; Sympathetic Nervous System; Symporters; Thiazolidines | 2005 |
Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Topics: 3-Iodobenzylguanidine; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Heart; Male; Metabolic Clearance Rate; Myocardium; Polymers; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhodanine; Signal Transduction; Sorbitol; Streptozocin; Sympathetic Nervous System | 2005 |
meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart: a marker for myocardial dysfunction?
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Animals; Biomarkers; Desoxycorticosterone; Diabetes Mellitus, Experimental; Heart; Hypertension; In Vitro Techniques; Iodobenzenes; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Spleen; Streptozocin | 1994 |
Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
Topics: 3-Iodobenzylguanidine; Animals; Diabetes Mellitus, Experimental; Heart; Hypertension; Iodine Radioisotopes; Iodobenzenes; Male; Norepinephrine; Radionuclide Imaging; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Zucker; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1996 |
Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
Topics: 3-Iodobenzylguanidine; Aldehyde Reductase; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Heart; Insulin; Iodine Radioisotopes; Male; Myocardium; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhodanine; Thiazolidines | 1997 |
Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Chromatography, High Pressure Liquid; Coronary Circulation; Desipramine; Diabetes Mellitus, Experimental; In Vitro Techniques; Male; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Symporters; Technetium Tc 99m Sestamibi | 2001 |